PMC-3

Country: Awstralja

Lingwa: Ingliż

Sors: Department of Health (Therapeutic Goods Administration)

Ixtrih issa

Ingredjent attiv:

Silybum marianum, Quantity: 500 mg (Equivalent: Silybum marianum, Qty 35 g); sugar cane wax alcohols, Quantity: 12 mg (Equivalent: octacosanol, Qty 7.2 mg); chromic chloride hexahydrate, Quantity: 1.026 mg (Equivalent: chromium, Qty 200 microgram)

Disponibbli minn:

Bellevue Health Pty Ltd

INN (Isem Internazzjonali):

chromic chloride hexahydrate,sugar cane wax alcohols,Silybum marianum

Għamla farmaċewtika:

Capsule, hard

Kompożizzjoni:

Excipient Ingredients: brilliant blue FCF; purified water; colloidal anhydrous silica; calcium hydrogen phosphate dihydrate; amaranth; magnesium stearate; sodium lauryl sulfate; tartrazine; Gelatin; macrogol 6000; titanium dioxide

Rotta amministrattiva:

Oral

Indikazzjonijiet terapewtiċi:

Antioxidant/Reduce free radicals formed in the body ; Helps reduce/decrease free radical damage to body cells ; Maintain/support general health and wellbeing ; Traditionally used in Western herbal medicine to Decrease/reduce/relieve symptoms of indigestion/dyspepsia ; Traditionally used in Western herbal medicine to Maintain/support bile production ; Traditionally used in Western herbal medicine to Maintain/support healthy liver function ; Traditionally used in Western herbal medicine to Maintain/support liver health ; Aid/assist/helps glucose/sugar/carbohydrate metabolism ; Aid/assist/helps metabolism of (state vitamin/mineral/nutrient)

Sommarju tal-prodott:

Visual Identification: ;

L-istatus ta 'awtorizzazzjoni:

Licence status A

Data ta 'l-awtorizzazzjoni:

2017-03-23

Ara l-istorja tad-dokumenti